Panelists:
Elena Erroba, PhD
Group Chief Commercial Officer
3PBIOVIAN
Panelist
Elena Erroba, PhD
Elena Erroba is the group CCO at 3PBIOVIAN. She specializes in the development and manufacturing of recombinant proteins and advanced therapies, including viral vectors—such as adenoviruses and adeno-associated viruses—and DNA plasmids.
- Time:
Bioprocessing has long been the backbone of drug development. Today, as the field evolves, advances in processes, equipment, and technology are improving efficiency and safety, helping organizations bring novel therapies and modalities to life. From streamlining cell and gene therapy production to integrating AI for smarter manufacturing, the bioprocessing landscape is rapidly transforming—with the goal to deliver therapies quickly, affordably, and at scale.
On this episode of GEN Live, industry experts will explore the current state of bioprocessing and how the field is tackling its biggest challenges. Topics to be discussed include: What are the latest trends in cell and gene therapy, automation, and quality control? How are companies scaling manufacturing to reduce costs? How is the role of CDMOs changing? And how is AI poised to transform biomanufacturing and drug development?
We’ll also preview the upcoming Bioprocessing International meeting in Boston.
Produced with support from:
The post How Bioprocessing Breakthroughs Are Shaping the Future of Medicine appeared first on GEN – Genetic Engineering and Biotechnology News.
